A detailed history of Geode Capital Management, LLC transactions in X Biotech Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 430,205 shares of XBIT stock, worth $3.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
430,205
Previous 195,204 120.39%
Holding current value
$3.14 Million
Previous $1.59 Million 39.32%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$4.54 - $9.89 $1.07 Million - $2.32 Million
235,001 Added 120.39%
430,205 $2.21 Million
Q1 2024

May 13, 2024

BUY
$4.03 - $8.13 $10,542 - $21,268
2,616 Added 1.36%
195,204 $1.59 Million
Q4 2023

Feb 13, 2024

BUY
$3.56 - $4.65 $35,066 - $45,802
9,850 Added 5.39%
192,588 $770,000
Q3 2023

Nov 13, 2023

BUY
$4.02 - $5.81 $38,419 - $55,526
9,557 Added 5.52%
182,738 $752,000
Q2 2023

Aug 11, 2023

BUY
$3.06 - $6.38 $55,379 - $115,465
18,098 Added 11.67%
173,181 $1.03 Million
Q4 2022

Feb 13, 2023

BUY
$3.03 - $3.79 $10,126 - $12,666
3,342 Added 2.2%
155,083 $544,000
Q3 2022

Nov 14, 2022

BUY
$3.58 - $5.88 $1,235 - $2,028
345 Added 0.23%
151,741 $549,000
Q2 2022

Aug 12, 2022

SELL
$5.13 - $9.2 $745,255 - $1.34 Million
-145,274 Reduced 48.97%
151,396 $852,000
Q1 2022

May 13, 2022

SELL
$8.64 - $11.71 $109,823 - $148,845
-12,711 Reduced 4.11%
296,670 $2.56 Million
Q4 2021

Feb 11, 2022

BUY
$10.95 - $16.07 $35,729 - $52,436
3,263 Added 1.07%
309,381 $3.44 Million
Q3 2021

Nov 12, 2021

BUY
$12.95 - $18.24 $106,138 - $149,495
8,196 Added 2.75%
306,118 $3.96 Million
Q2 2021

Aug 13, 2021

BUY
$15.83 - $17.84 $390,747 - $440,362
24,684 Added 9.03%
297,922 $4.93 Million
Q1 2021

May 12, 2021

BUY
$15.92 - $20.3 $522,987 - $666,875
32,851 Added 13.67%
273,238 $4.69 Million
Q4 2020

Feb 12, 2021

SELL
$15.65 - $19.92 $47,294 - $60,198
-3,022 Reduced 1.24%
240,387 $3.76 Million
Q3 2020

Nov 13, 2020

SELL
$13.97 - $21.16 $254,980 - $386,212
-18,252 Reduced 6.98%
243,409 $4.65 Million
Q2 2020

Aug 13, 2020

SELL
$10.39 - $16.07 $155,818 - $241,001
-14,997 Reduced 5.42%
261,661 $3.59 Million
Q1 2020

May 14, 2020

SELL
$8.89 - $24.94 $531,808 - $1.49 Million
-59,821 Reduced 17.78%
276,658 $2.94 Million
Q4 2019

Feb 13, 2020

BUY
$8.33 - $19.95 $271,116 - $649,312
32,547 Added 10.71%
336,479 $6.28 Million
Q3 2019

Nov 12, 2019

BUY
$6.86 - $10.46 $40,995 - $62,508
5,976 Added 2.01%
303,932 $3.18 Million
Q2 2019

Aug 14, 2019

BUY
$6.99 - $11.27 $923,309 - $1.49 Million
132,090 Added 79.64%
297,956 $2.26 Million
Q1 2019

May 14, 2019

BUY
$5.05 - $11.62 $155,050 - $356,768
30,703 Added 22.72%
165,866 $1.83 Million
Q3 2018

Nov 13, 2018

BUY
$2.31 - $4.69 $18,678 - $37,923
8,086 Added 6.36%
135,163 $429,000
Q2 2018

Aug 14, 2018

SELL
$4.04 - $5.13 $172,625 - $219,199
-42,729 Reduced 25.16%
127,077 $569,000
Q1 2018

May 15, 2018

BUY
$3.92 - $5.35 $14,233 - $19,425
3,631 Added 2.19%
169,806 $908,000
Q4 2017

Feb 13, 2018

SELL
$3.9 - $4.66 $13,938 - $16,654
-3,574 Reduced 2.11%
166,175 $654,000
Q3 2017

Nov 14, 2017

BUY
$4.14 - $5.12 $29,543 - $36,536
7,136 Added 4.39%
169,749 $741,000
Q2 2017

Aug 14, 2017

BUY
N/A
162,613
162,613 $764,000

Others Institutions Holding XBIT

About XBiotech Inc.


  • Ticker XBIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,439,300
  • Market Cap $222M
  • Description
  • XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...
More about XBIT
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.